| Typicality: | 0.552 |
| Saliency: | 0.654 |
| in canada | 34 | location |
| in children | 20 | transitive-object |
| in a number of european countries | 16 | location |
| vaccine → be approved for → use | 176 |
| vaccine → be → approved | 148 |
| vaccine → be approved for → people | 19 |
| vaccine → be approved for → human use | 5 |
| vaccine → be approved for → clinical trials | 5 |
| vaccine → be approved → effective | 5 |
| vaccine → be approved for → patient | 4 |
| vaccine → be approved for → administration | 3 |
| negative | neutral | positive |
| 0.166 | 0.581 | 0.253 |
| Raw frequency | 365 |
| Normalized frequency | 0.654 |
| Modifier score | 0.571 |
| Perplexity | 60.150 |